Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00798122 · ClinicalTrials.gov registry record · NA
Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease
A NA study of Acute Coronary Syndromes, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00798122 is a NA study of Acute Coronary Syndromes that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 820-participant average among 3 other Acute Coronary Syndromes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00798122, a NA study of Acute Coronary Syndromes, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 600,000 women are treated for acute coronary syndrome (ACS) annually in the US. ACS includes heart attack and a milder form called unstable angina. Many of these women have angiograms of which 14-39% show no "significant" coronary artery disease (CAD, cholesterol plaque accumulation in arteries of the heart). The remaining majority of women with ACS have cholesterol plaque buildup which appears severe enough on angiography to limit blood flow to the heart. It is difficult to advise women with heart attacks and no major heart artery blockages on what to do if chest pain happens again. Additional studies are needed to find out why this sort of heart attack happens and to help doctors understand how to treat patients who have this problem in the best possible way. Some women with heart attacks who have no major blockage in heart arteries have cholesterol plaque in the arteries of the heart cannot be seen on angiography but can be seen using a newer technique called intravascular ultrasound (IVUS). IVUS involves creating pictures of the artery walls using ultrasound (sound waves) from within the artery itself. In some women without major heart artery blockage, heart attack is caused by low blood flow due to disease of smaller blood vessels which cannot be seen on angiography or IVUS. This problem can be found using magnetic resonance imaging (MRI), which can show blood flow to the heart. MRI may also be used to show where the heart has been damaged. The pattern of damage could suggest that a heart attack in a woman, who has no badly blocked heart arteries, happened for one (or more) of these reasons or another reason. The Study of Women with ACS and Non-obstructive CAD (SWAN) will use IVUS and MRI to help determine the reasons for heart attacks in women with no major blockages in heart arteries.
Conditions Studied
Interventions
- PROCEDURE MRI
- PROCEDURE Intravascular ultrasound
Study Locations (1)
New York
- NYU Medical Center and Bellevue Hospital Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-03-01 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00798122
The ClinicalTrials.gov registry entry for NCT00798122 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 820-participant average among 3 other Acute Coronary Syndromes trials with a reported enrollment target (94% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Coronary Syndromes appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT00798122 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00798122 about?
NCT00798122 is a clinical study titled "Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease". Approximately 600,000 women are treated for acute coronary syndrome (ACS) annually in the US. ACS includes heart attack and a milder form called unstable angina. Many of these women have angiograms of which 14-39% show no "significant" coronary artery disease (CAD, cholesterol plaque accumulation in...
What is the current status of trial NCT00798122?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2006-03-01. Estimated completion is 2027-07-01.
What conditions does trial NCT00798122 study?
This clinical trial studies the following conditions: Acute Coronary Syndromes.
What interventions are being tested in trial NCT00798122?
The interventions under investigation include: MRI (PROCEDURE), Intravascular ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT00798122?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00798122 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.